文献速递功能神经外科

立体定向放射外科治疗震颤:系统综述

Stereotactic radiosurgery for tremor: systematic review.
PubMed 文献 · J Neurosurg · 2018-02-23

本系统综述检索至2016年12月,纳入34篇全文文献,其中3项前瞻性研究、1项回顾性比较研究、30项回顾性研究。单侧丘脑腹中间核立体定向放射外科(剂量130-150 Gy)可有效减轻药物难治性震颤且耐受性良好,获国际立体定向放射外科学会推荐。

要点

  • 34篇文献中3项前瞻性、1项回顾性比较、30项回顾性研究。
  • SRS丘脑毁损术平均震颤减少率为88%。
  • 临床并发症少见且通常不永久(范围0%-100%,均值17%,中位数2%)。

核心结论

  • 单侧丘脑腹中间核立体定向放射外科,剂量130-150 Gy,是减轻药物难治性震颤的耐受性良好且有效的治疗,并获得国际立体定向放射外科学会推荐。

研究设计与样本

  • 系统综述,检索MEDLINE(PubMed)与EMBASE至2016年12月,不限制研究设计但仅纳入英文关键词文献,摘要至少为英文。
  • 共纳入34篇全文文献:3项前瞻性研究、1项回顾性比较研究、30项回顾性研究。

主要发现

  • 唯一一项比较脑深部电刺激(DBS)、射频热凝(RFT)与SRS的回顾性比较研究报告三者震颤控制率相似。
  • 该比较研究还报告DBS与RFT后永久性并发症更多、RFT后复发更多,而SRS起效潜伏期更长。
  • 多数报告中SRS丘脑毁损术的震颤减少率相似,平均88%。
  • 临床并发症少见且通常不永久,范围0%-100%,均值17%,中位数2%。
  • 随访总体上过短,无法确认长期结果。

关键数值与推荐

  • SRS靶点为单侧丘脑腹中间核,剂量130-150 Gy。
  • 国际立体定向放射外科学会推荐该治疗用于药物难治性震颤。

临床怎么用

  • 国际立体定向放射外科学会推荐单侧丘脑腹中间核SRS(剂量130-150 Gy)用于药物难治性震颤。

局限性

  • 随访总体上过短,无法确认长期结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this systematic review is to offer an objective summary of the published literature relating to stereotactic radiosurgery (SRS) for tremor and consensus guideline recommendations. METHODS: This systematic review was performed up to December 2016. Article selection was performed by searching the MEDLINE (PubMed) and EMBASE electronic bibliographic databases. The following key words were used: "radiosurgery" and "tremor" or "Parkinson's disease" or "multiple sclerosis" or "essential tremor" or "thalamotomy" or "pallidotomy." The search strategy was not limited by study design but only included key words in the English language, so at least the abstract had to be in English. RESULTS: A total of 34 full-text articles were included in the analysis. Three studies were prospective studies, 1 was a retrospective comparative study, and the remaining 30 were retrospective studies. The one retrospective comparative study evaluating deep brain stimulation (DBS), radiofrequency thermocoagulation (RFT), and SRS reported similar tremor control rates, more permanent complications after DBS and RFT, more recurrence after RFT, and a longer latency period to clinical response with SRS. Similar tremor reduction rates in most of the reports were observed with SRS thalamotomy (mean 88%). Clinical complications were rare and usually not permanent (range 0%-100%, mean 17%, median 2%). Follow-up in general was too short to confirm long-term results. CONCLUSIONS: SRS to the unilateral thalamic ventral intermediate nucleus, with a dose of 130-150 Gy, is a well-tolerated and effective treatment for reducing medically refractory tremor, and one that is recommended by the International Stereotactic Radiosurgery Society.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Martínez-Moreno NE, Sahgal A, De Salles A, et al. Stereotactic radiosurgery for tremor: systematic review. J Neurosurg. 2018. PMID: 29473775. doi:10.3171/2017.8.JNS17749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。